Home/Filings/4/0001437749-12-009902
4//SEC Filing

Tavakkol Roxanne 4

Accession 0001437749-12-009902

CIK 0000352747other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 4:24 PM ET

Size

6.9 KB

Accession

0001437749-12-009902

Insider Transaction Report

Form 4
Period: 2012-09-27
Tavakkol Roxanne
Vice President
Transactions
  • Award

    Stock Option

    2012-09-27+120,782486,788 total
    Exercise: $0.25Exp: 2022-09-26Common Stock (120,782 underlying)
  • Award

    Stock Option

    2012-09-27+545,0001,031,788 total
    Exercise: $0.10From: 2013-09-27Exp: 2022-09-26Common Stock (545,000 underlying)
Footnotes (1)
  • [F1]60,391 stock options will become exercisable on August 1, 2013 and 60,391 stock options will become exercisable on August 1, 2014

Issuer

UNIGENE LABORATORIES INC

CIK 0000352747

Entity typeother

Related Parties

1
  • filerCIK 0001502054

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 4:24 PM ET
Size
6.9 KB